A detailed history of Virginia Retirement Systems Et Al transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 56,900 shares of VIR stock, worth $455,769. This represents 0.01% of its overall portfolio holdings.

Number of Shares
56,900
Previous 39,900 42.61%
Holding current value
$455,769
Previous $978,000 45.5%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$9.14 - $24.62 $155,380 - $418,540
17,000 Added 42.61%
56,900 $533,000
Q2 2023

Aug 22, 2023

SELL
$23.2 - $27.29 $74,240 - $87,328
-3,200 Reduced 7.42%
39,900 $978,000
Q1 2023

Jul 11, 2023

BUY
$22.26 - $30.85 $414,036 - $573,810
18,600 Added 75.92%
43,100 $1 Million
Q4 2022

May 17, 2023

BUY
$19.96 - $28.22 $113,772 - $160,854
5,700 Added 30.32%
24,500 $620 Million
Q3 2022

May 16, 2023

BUY
$18.26 - $31.1 $343,288 - $584,680
18,800 New
18,800 $362 Million

Others Institutions Holding VIR

About Vir Biotechnology, Inc.


  • Ticker VIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 132,638,000
  • Market Cap $1.06B
  • Description
  • Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...
More about VIR
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.